Nanomerics Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nanomerics Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11201
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nanomerics Ltd (Nanomerics) is a healthcare solution provider that develops drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. The company offers products such as METDoloron, METSporine, METAmphizon, METEnkalon, MET undisclosed, MET ocular undiscl, ocular undiscl, NCE undisclosed. It also offers polymer based nanomedicines constructed from the self-assembly of amphiphilic polymers and dendrimers. Nanomerics develops its products by using molecular envelope technology that increases bioavailability of hydrophobic drugs and peptides. The company serves pharmaceutical and healthcare sectors. Nanomerics is headquartered in London, the UK.

Nanomerics Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanomerics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Nemus Bioscience Enters into Development Agreement with Nanomerics 10
Nanomerics, University College London and Lundbeck Enter Collaboration Agreement 11
Licensing Agreements 12
IACTA Pharma Enters into Licensing Agreement with Nanomerics 12
Equity Offering 13
Nanomerics Spin Out from University College London 13
Nanomerics Ltd – Key Competitors 14
Nanomerics Ltd – Key Employees 15
Nanomerics Ltd – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Nanomerics Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanomerics Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanomerics Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nemus Bioscience Enters into Development Agreement with Nanomerics 10
Nanomerics, University College London and Lundbeck Enter Collaboration Agreement 11
IACTA Pharma Enters into Licensing Agreement with Nanomerics 12
Nanomerics Spin Out from University College London 13
Nanomerics Ltd, Key Competitors 14
Nanomerics Ltd, Key Employees 15

List of Figures
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nanomerics Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Nanomerics Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Adient Plc (ADNT):企業の財務・戦略的SWOT分析
    Adient Plc (ADNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • HudBay Minerals Inc:企業のM&A・事業提携・投資動向
    HudBay Minerals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's HudBay Minerals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • adidas AG (ADS):企業の財務・戦略的SWOT分析
    adidas AG (ADS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Arzeda Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Arzeda Corp (Arzeda) is a biotechnology company that develops biological solutions for transformative products. The company’s products include novel crop traits, 1, 3-butadiene, levulinic acid, and methane. Its services comprise enzyme design, metabolic engineering, and protein optimization …
  • Aptitude Medical Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Aptitude Medical Systems Inc (Aptitude Medical) is a developer of dynamic proteins, lipids, sugars and metabolites. The company's target range comprises nonimmunogenic proteins, peptides, toxins, glycans, drugs, metabolites and small epitopes. Its integrated suite of proprietary technologies …
  • Turkiye Petrol Rafinerileri AS (TUPRS):企業の財務・戦略的SWOT分析
    Turkiye Petrol Rafinerileri AS (TUPRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • UPM-Kymmene Corp:企業の戦略・SWOT・財務分析
    UPM-Kymmene Corp - Strategy, SWOT and Corporate Finance Report Summary UPM-Kymmene Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Taisho Pharmaceutical Holdings Co Ltd:戦略・SWOT・企業財務分析
    Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Taisho Pharmaceutical Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Bengal Energy Ltd Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Bengal Energy Ltd (Bengal Energy), formerly Avery Resources Inc is an oil and gas exploration and production company that acquires, explores, and produces prospective light oil-weighted onshore assets …
  • Mangalore Refinery and Petrochemicals Ltd (MRPL):企業の財務・戦略的SWOT分析
    Mangalore Refinery and Petrochemicals Ltd (MRPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • InspireMD Inc (NSPR):医療機器:M&Aディール及び事業提携情報
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Garfunkelux Holdco 2 SA:企業の戦略的SWOT分析
    Garfunkelux Holdco 2 SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Ceska pojistovna a.s.:企業の戦略的SWOT分析
    Ceska pojistovna a.s. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Aggreko Plc (AGK):企業の財務・戦略的SWOT分析
    Aggreko Plc (AGK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Singapore Petroleum Co Ltd:企業の戦略的SWOT分析
    Singapore Petroleum Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • CSR Ltd:企業の戦略・SWOT・財務情報
    CSR Ltd - Strategy, SWOT and Corporate Finance Report Summary CSR Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Guernsey Electricity Limited:発電所・企業SWOT分析
    Guernsey Electricity Limited - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • Denali Therapeutics Inc (DNLI):製薬・医療:M&Aディール及び事業提携情報
    Summary Denali Therapeutics Inc (Denali Therapeutics) is a clinical-stage biopharmaceutical company that focuses on the development of therapeutics for the treatment of neurodegenerative diseases. The company’s proprietary drug delivery platform technologies include antibody transport vehicle and en …
  • Acom Co., Ltd.:企業の戦略・SWOT・財務情報
    Acom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Acom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Dimerix Bioscience Pty Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Dimerix Bioscience Pty Ltd (Dimerix), a subsidiary of Sun Biomedical Ltd is a biopharmaceutical company that offers drug discovery assays and progressing clinical programs. The company provides product development, discovery services, and others. It provides Receptor-HIT a cell-based assay a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆